Nov 17 - Britain's FTSE 100 index is seen opening 12 points lower at 6,409 on Tuesday, according to financial bookmakers * COVID-19: Britain has secured 5 million doses of an experimental COVID-19 vaccine developed by Moderna Inc after it reported positive trial results, health minister Matt Hancock said on Monday, with the earliest doses expected for delivery in spring. * BREXIT: European Union diplomats warned Britain on Monday that time was fast running out for a Brexit deal, and that it may already be too late to ratify one, as negotiators in Brussels began a last-ditch attempt to avoid a tumultuous exit at the end of December. * GOLD: Gold prices edged higher as the dollar slipped, while investors weighed concerns over spiking coronavirus cases globally against optimism over positive developments around a second possible COVID-19 vaccine. * OIL: Oil prices edged higher on expectations OPEC and its allies will extend oil production cuts for at least three months, while sentiment was bolstered by news of another promising coronavirus vaccine. * The UK blue-chip index closed 1.7% higher on Monday as positive vaccine data from drugmaker Moderna bolstered hopes of a swift economic recovery to pre-pandemic levels, offsetting concerns over a post-Brexit trade deal with the European Union. * UK CORPORATE DIARY: Ninety One Plc HY earnings EasyJet Plc FY earnings Big Yellow Group Plc HY earnings Assura Plc HY earnings Imperial Brands Plc FY earnings Aggreko Plc Q3 trading statement Telecom Plus Plc HY results HomeServe Plc HY earnings Intermediate Capital Group Plc HY earnings Experian Plc HY earnings Focusrite Plc FY earnings * For more on the factors affecting European stocks, please click on: TODAY'S UK PAPERS > Financial Times > Other business headlines (Reporting by Priyanshi Mandhan)
Our Standards: The Thomson Reuters Trust Principles.